TrialBlood advances2025

Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial.

Anna Maria Raiola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.